Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Gasmi

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Clinical Investigation|February 4, 2009
Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stressMichael I Dorrell, Edith Aguilar, Ruth Jacobson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2006
Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's diseaseJodi L McBride, Shilpa Ramaswamy, Mehdi Gasmi, et al.
Neurosurgery|April 8, 2009
Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's diseaseChristopher D Herzog, Lamar Brown, Dawn Gammon, et al.
Neurobiology of Disease|May 29, 2007
AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's diseaseMehdi Gasmi, Eugene P Brandon, Christopher D Herzog, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2008
Transgene expression, bioactivity, and safety of CERE-120 (AAV2-neurturin) following delivery to the monkey striatumChristopher D Herzog, Biplob Dass, Mehdi Gasmi, et al.
Translational Vision Science & Technology|February 3, 2021
Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman PrimatesSzilárd Kiss, Kristina Oresic Bender, Ruslan N Grishanin, et al.
Neurobiology of Disease|January 13, 2009
Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALSColin K Franz, Thais Federici, Jun Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patientsCaroline Le Guiner, Marie Montus, Laurent Servais, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Clinical Investigation|February 4, 2009
Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stressMichael I Dorrell, Edith Aguilar, Ruth Jacobson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2006
Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's diseaseJodi L McBride, Shilpa Ramaswamy, Mehdi Gasmi, et al.
Neurosurgery|April 8, 2009
Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's diseaseChristopher D Herzog, Lamar Brown, Dawn Gammon, et al.
Neurobiology of Disease|May 29, 2007
AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's diseaseMehdi Gasmi, Eugene P Brandon, Christopher D Herzog, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2008
Transgene expression, bioactivity, and safety of CERE-120 (AAV2-neurturin) following delivery to the monkey striatumChristopher D Herzog, Biplob Dass, Mehdi Gasmi, et al.
Translational Vision Science & Technology|February 3, 2021
Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman PrimatesSzilárd Kiss, Kristina Oresic Bender, Ruslan N Grishanin, et al.
Neurobiology of Disease|January 13, 2009
Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALSColin K Franz, Thais Federici, Jun Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patientsCaroline Le Guiner, Marie Montus, Laurent Servais, et al.
Pageof 3